Polaris Capital Management LLC held its position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 76,800 shares of the company’s stock at the end of the 2nd quarter. Polaris Capital Management LLC owned about 0.19% of Phibro Animal Health Corporation worth $2,845,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. State of Alaska Department of Revenue increased its position in Phibro Animal Health Corporation by 80.9% in the 2nd quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after acquiring an additional 1,650 shares during the period. Mason Street Advisors LLC increased its position in Phibro Animal Health Corporation by 7.1% in the 1st quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock valued at $122,000 after acquiring an additional 286 shares during the period. Municipal Employees Retirement System of Michigan increased its position in Phibro Animal Health Corporation by 3.6% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after acquiring an additional 150 shares during the period. KBC Group NV acquired a new stake in Phibro Animal Health Corporation in the 2nd quarter valued at approximately $166,000. Finally, Victory Capital Management Inc. increased its position in Phibro Animal Health Corporation by 79.2% in the 1st quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock valued at $129,000 after acquiring an additional 2,021 shares during the period. Hedge funds and other institutional investors own 48.04% of the company’s stock.

Shares of Phibro Animal Health Corporation (PAHC) remained flat at $37.00 during trading on Thursday. 37,162 shares of the company’s stock traded hands. The stock’s 50 day moving average price is $36.59 and its 200 day moving average price is $34.97. Phibro Animal Health Corporation has a 52-week low of $24.83 and a 52-week high of $40.25. The firm has a market capitalization of $1.48 billion, a PE ratio of 22.98 and a beta of 1.36.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The firm had revenue of $194.84 million during the quarter, compared to analysts’ expectations of $192.47 million. During the same quarter in the previous year, the company posted $0.32 EPS. Phibro Animal Health Corporation’s revenue was up 3.0% on a year-over-year basis. On average, equities research analysts predict that Phibro Animal Health Corporation will post $1.56 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th were given a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 1.08%. The ex-dividend date was Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is presently 24.69%.

COPYRIGHT VIOLATION NOTICE: “Polaris Capital Management LLC Continues to Hold Position in Phibro Animal Health Corporation (PAHC)” was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://theolympiareport.com/2017/10/12/polaris-capital-management-llc-continues-to-hold-position-in-phibro-animal-health-corporation-pahc.html.

Several equities analysts have recently issued reports on the company. BidaskClub cut Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Piper Jaffray Companies set a $35.00 price target on Phibro Animal Health Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Bank of America Corporation reiterated an “underperform” rating and set a $33.00 price target on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Finally, Credit Suisse Group lifted their price target on Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an “outperform” rating in a research report on Thursday, August 31st. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $33.00.

In other Phibro Animal Health Corporation news, CFO Richard G. Johnson sold 29,807 shares of the company’s stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $35.66, for a total transaction of $1,062,917.62. Following the completion of the sale, the chief financial officer now owns 4,240 shares in the company, valued at approximately $151,198.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Daniel M. Bendheim sold 1,443 shares of the company’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $40.05, for a total transaction of $57,792.15. Following the sale, the vice president now owns 300 shares of the company’s stock, valued at approximately $12,015. The disclosure for this sale can be found here. Insiders sold a total of 292,448 shares of company stock valued at $10,624,994 in the last 90 days. 51.88% of the stock is currently owned by corporate insiders.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.